ePatient Enroll Announces a Record Third Quarter

LAS VEGAS - Oct. 18, 2016 - PRLog -- ePatient Enroll, Inc., a leading, full-service provider of global patient enrollment and retention solutions, announced today that the third quarter was a new company record in terms of new business, revenue, backlog, and new customers signed in a three-month period.

Relative sales for the quarter were up 75% compared to Q3 2015, a noteworthy accomplishment since the company exceeded revenue and patient recruitment goals in 2015. In addition, e-Patient Enroll signed a record number of Biopharmaceutical clients in a single quarter, further expanding its footprint within the biopharmaceutical and medical device arenas.

"Clearly, as a company we are very satisfied although we are well aware that ePatient Enroll can certainly improve on this performance as we enter into the new year," stated Devon Parks, ePatient Enroll's Director of Recruiting. "In 2016 we stretched our global capabilities and services beyond the US and European zones. As our consistent growth and enrollment numbers show, we expect to see continued support and repeat business from both Biopharmaceutical and Medical device clients.

The company believes that it is well positioned for continued growth as drug developers continue to face enormous pressure to meet investor expectations and tight enrollment timelines for their respective trials.

"e-Patient Enroll has already developed the technology, processes, and trained staff which are so vital when meeting todays difficult enrollment environment. Our clients are looking for results driven patient enrollment solutions that not only matches qualified subjects to the right site but allows them to see a global view of how their investment is paying off." stated Devon.

About E-Patient Enroll

ePatient Enroll is a global provider of clinical trial patient recruitment and retention services for a wide array Biopharmaceutical and Medical device developers. ePatient Enroll engages ePatients to increase enrollment performance for research centers globally. The companies' eCentric platform provides a comprehensive patient- centric program designed to connect ePatients to clinical research when it matters most. As a result, trial sponsors can now complete enrollment on time and under budget.

To learn more, please visit https://epatientenroll.com